Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$33.65 USD
+1.26 (3.89%)
Updated Aug 13, 2024 03:59 PM ET
After-Market: $33.64 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 0.41 |
EPS Last Quarter | 0.36 |
Last EPS Surprise | -2.70% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.03 |
Next Year | 1.92 |
EPS (TTM) | 0.09 |
P/E (F1) | 15.96 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 155.96M | 154.29M | 622.24M | 619.31M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 159.39M | 155.50M | 623.80M | 648.50M |
Low Estimate | 152.00M | 152.06M | 619.50M | 595.80M |
Year ago Sales | 153.88M | 164.31M | 607.52M | 622.24M |
Year over Year Growth Est. | 1.35% | -6.10% | 2.42% | -0.47% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.41 | 0.44 | 2.03 | 1.92 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.43 | 0.44 | 2.09 | 2.44 |
Low Estimate | 0.39 | 0.43 | 1.95 | 1.18 |
Year ago EPS | -0.29 | 0.02 | 0.02 | 2.03 |
Year over Year Growth Est. | 241.38% | 2,100.00% | 10,050.00% | -5.26% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 1 | 1 | 3 | 0 |
Up Last 60 Days | 1 | 1 | 3 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 1 | 1 | 0 | 3 |
Down Last 60 Days | 1 | 1 | 0 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.41 | 0.44 | 2.03 | 1.92 |
7 Days Ago | 0.39 | 0.48 | 1.75 | 2.10 |
30 Days Ago | 0.39 | 0.48 | 1.75 | 2.10 |
60 Days Ago | 0.39 | 0.48 | 1.75 | 2.10 |
90 Days Ago | 0.39 | 0.48 | 1.75 | 2.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.41 | 0.44 | 2.03 | 1.92 |
Zacks Consensus Estimate | 0.41 | 0.44 | 2.03 | 1.92 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.36 | 0.00 | 0.02 | -0.29 | NA |
Estimate | 0.37 | 0.39 | 0.41 | 0.13 | NA |
Difference | -0.01 | -0.39 | -0.39 | -0.42 | -0.30 |
Surprise | -2.70% | -100.00% | -95.12% | -323.08% | -130.23% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more